Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN) shares gapped up prior to trading on Tuesday . The stock had previously closed at $21.82, but opened at $22.99. Anbio Biotechnology shares last traded at $21.41, with a volume of 3,453 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Anbio Biotechnology currently has a consensus rating of “Hold”.

Anbio Biotechnology Price Performance

Anbio Biotechnology (NASDAQ:NNNN) last announced its earnings results on Tuesday, December 30th. The company reported $0.04 EPS for the quarter. The firm had revenue of $2.29 million for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.